Friday, May 5, 2017

GOLD 2017 recommendations for COPD patients: toward a more personalized approach (Free full text from COPD Research and Practice)

The Global Initiative for Chronic Obstructive Lung Disease (GOLD), an international committee of experts, has recently published its updated report on diagnosis and management of Chronic Obstructive Pulmonary Disease (COPD). Compared to the previous version, this documents has been an extensively revised: the definition has been simplified, highlighting the importance of respiratory symptoms, and disease development is further discussed, including new insights on lung development. Spirometry is still required for the diagnosis, and it is described as fundamental tool for evaluating prognosis, disease progression, and non-pharmacologic treatment.
However, differently from the previous version, spirometry is no longer included in the ABCD tool (ie, a practical tool proposed to assess COPD symptom burden and guide pharmacologic treatment), which is now centered exclusively on respiratory symptoms and history of exacerbation. Subsequently, pharmacologic treatment has been shifted towards a more personalized approach, reflecting the ongoing process toward a comprehensive, patient-tailored management.
Free full text:

1 comment:

  1. I think that this is very good. I feel that spirometry is used so much I can remember when at the age of 45 I had a spirometry and found it very difficult to do although very fit I had asthma and my spirometry test came back at 30% it must have been wrong because I was too fit working and running up and down stairs. I have always found the spirometry difficult to blow into and then being depressed for days on end afterwards I think some people just have a terrible technique.